GB0524062D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0524062D0
GB0524062D0 GB0524062A GB0524062A GB0524062D0 GB 0524062 D0 GB0524062 D0 GB 0524062D0 GB 0524062 A GB0524062 A GB 0524062A GB 0524062 A GB0524062 A GB 0524062A GB 0524062 D0 GB0524062 D0 GB 0524062D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0524062A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0524062A priority Critical patent/GB0524062D0/en
Publication of GB0524062D0 publication Critical patent/GB0524062D0/en
Priority to KR1020137031544A priority patent/KR20130140909A/en
Priority to JP2008541641A priority patent/JP5844508B2/en
Priority to MYPI20081624A priority patent/MY146403A/en
Priority to EP06818763A priority patent/EP1960380A1/en
Priority to KR1020137031545A priority patent/KR20130137721A/en
Priority to UY29964A priority patent/UY29964A1/en
Priority to PCT/EP2006/011240 priority patent/WO2007059963A1/en
Priority to CA2824307A priority patent/CA2824307C/en
Priority to CA2628330A priority patent/CA2628330C/en
Priority to CN2006800440077A priority patent/CN101312960B/en
Priority to US12/094,629 priority patent/US7893076B2/en
Priority to CA2824301A priority patent/CA2824301C/en
Priority to KR1020087012363A priority patent/KR20080078804A/en
Priority to EP12177119A priority patent/EP2546248A1/en
Priority to BRPI0618993-8A priority patent/BRPI0618993A2/en
Priority to ARP060105173 priority patent/AR057923A1/en
Priority to EP12177131.5A priority patent/EP2578580A1/en
Priority to RU2008125299/04A priority patent/RU2008125299A/en
Priority to AU2006316823A priority patent/AU2006316823A1/en
Priority to KR1020137031543A priority patent/KR20130141712A/en
Priority to CN201110232553.6A priority patent/CN102351842B/en
Priority to EC2008008473A priority patent/ECSP088473A/en
Priority to NO20082684A priority patent/NO20082684L/en
Priority to US13/006,505 priority patent/US8198289B2/en
Priority to AU2011201286A priority patent/AU2011201286A1/en
Priority to US13/183,600 priority patent/US8846706B2/en
Priority to US13/183,557 priority patent/US8507515B2/en
Priority to US13/183,572 priority patent/US8592440B2/en
Priority to US13/472,000 priority patent/US8633213B2/en
Priority to JP2014005741A priority patent/JP2014074067A/en
Ceased legal-status Critical Current

Links

GB0524062A 2005-11-25 2005-11-25 Organic compounds Ceased GB0524062D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GB0524062A GB0524062D0 (en) 2005-11-25 2005-11-25 Organic compounds
CA2824301A CA2824301C (en) 2005-11-25 2006-11-23 F, g, h, i and k crystal forms of imatinib mesylate
EP12177119A EP2546248A1 (en) 2005-11-25 2006-11-23 Crystal form H of imatinib mesylate
EP12177131.5A EP2578580A1 (en) 2005-11-25 2006-11-23 G, I and K crystal forms of imatinib mesylate
BRPI0618993-8A BRPI0618993A2 (en) 2005-11-25 2006-11-23 imatinib mesylate f, g, h, i and k crystal forms
EP06818763A EP1960380A1 (en) 2005-11-25 2006-11-23 F,g,h,i and k crystal forms of imatinib mesylate
KR1020137031545A KR20130137721A (en) 2005-11-25 2006-11-23 F, g, h, i and k crystal forms of imatinib mesylate
UY29964A UY29964A1 (en) 2005-11-25 2006-11-23 CRYSTAL FORMS F, G, H, I, AND K OF THE IMATINIB MESILATE
PCT/EP2006/011240 WO2007059963A1 (en) 2005-11-25 2006-11-23 F,g,h,i and k crystal forms of imatinib mesylate
CA2824307A CA2824307C (en) 2005-11-25 2006-11-23 F, g, h, i and k crystal forms of imatinib mesylate
CA2628330A CA2628330C (en) 2005-11-25 2006-11-23 F,g,h,i and k crystal forms of imatinib mesylate
CN2006800440077A CN101312960B (en) 2005-11-25 2006-11-23 F,G,H,I and K crystal forms of imatinib mesylate
US12/094,629 US7893076B2 (en) 2005-11-25 2006-11-23 Crystalline form F of Imatinib mesylate
JP2008541641A JP5844508B2 (en) 2005-11-25 2006-11-23 F crystal form of imatinib mesylate
KR1020087012363A KR20080078804A (en) 2005-11-25 2006-11-23 F, g, h, i and k crystal forms of imatinib mesylate
KR1020137031544A KR20130140909A (en) 2005-11-25 2006-11-23 F, g, h, i and k crystal forms of imatinib mesylate
MYPI20081624A MY146403A (en) 2005-11-25 2006-11-23 F, g, h, i and k crystal forms of imatinib mesylate
ARP060105173 AR057923A1 (en) 2005-11-25 2006-11-23 GLASS FORMS F, G, H, I AND K OF THE ADDITION SALTS OF THE IMATINIB MESILATE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TUMORS AND DIFFERENT TYPES OF LEUKEMIA.
CN201110232553.6A CN102351842B (en) 2005-11-25 2006-11-23 F,G,H,I and K crystal forms of imatinib mesylate
RU2008125299/04A RU2008125299A (en) 2005-11-25 2006-11-23 CRYSTALLINE F-, G-, H-, I- AND K-FORMS OF IMATINIBMESILATE
AU2006316823A AU2006316823A1 (en) 2005-11-25 2006-11-23 F,G,H,I and K crystal forms of imatinib mesylate
KR1020137031543A KR20130141712A (en) 2005-11-25 2006-11-23 F, g, h, i and k crystal forms of imatinib mesylate
EC2008008473A ECSP088473A (en) 2005-11-25 2008-05-20 GLASS FORMS F, G, H, I, and K OF THE IMATINIB MESILATE
NO20082684A NO20082684L (en) 2005-11-25 2008-06-16 F, G, H, I and K crystal forms of imatinib mesylate
US13/006,505 US8198289B2 (en) 2005-11-25 2011-01-14 Crystal form H imatinib mesylate for pharmaceutical use
AU2011201286A AU2011201286A1 (en) 2005-11-25 2011-03-22 F,G,H,I and K crystal forms of imatinib mesylate
US13/183,600 US8846706B2 (en) 2005-11-25 2011-07-15 Crystalline form K of imatinib mesylate
US13/183,557 US8507515B2 (en) 2005-11-25 2011-07-15 Crystalline form G of imatinib mesylate
US13/183,572 US8592440B2 (en) 2005-11-25 2011-07-15 Crystalline form I of imatinib mesylate
US13/472,000 US8633213B2 (en) 2005-11-25 2012-05-15 Crystalline form F of imatinib mesylate
JP2014005741A JP2014074067A (en) 2005-11-25 2014-01-16 F, g, h, i and k crystal forms of imatinib mesylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0524062A GB0524062D0 (en) 2005-11-25 2005-11-25 Organic compounds

Publications (1)

Publication Number Publication Date
GB0524062D0 true GB0524062D0 (en) 2006-01-04

Family

ID=35601241

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0524062A Ceased GB0524062D0 (en) 2005-11-25 2005-11-25 Organic compounds

Country Status (1)

Country Link
GB (1) GB0524062D0 (en)

Similar Documents

Publication Publication Date Title
GB0510390D0 (en) Organic compounds
EP1888534A4 (en) Organic compounds
GB0507575D0 (en) Organic compounds
GB0500435D0 (en) Organic compounds
GB0500785D0 (en) Organic compounds
GB0508319D0 (en) Organic compounds
GB0505969D0 (en) Organic compounds
GB0502358D0 (en) Organic compounds
GB0507696D0 (en) Organic compounds
GB0507577D0 (en) Organic compounds
GB0503646D0 (en) Organic compounds
GB0504850D0 (en) Organic compounds
GB0505219D0 (en) Organic compounds
GB0504194D0 (en) Organic compounds
GB0510810D0 (en) Organic compounds
GB0508992D0 (en) Organic compounds
GB0504544D0 (en) Organic compounds
GB0511060D0 (en) Organic compounds
GB0501237D0 (en) Organic compounds
GB0500784D0 (en) Organic compounds
GB0504203D0 (en) Organic compounds
GB0500683D0 (en) Organic compounds
GB0507695D0 (en) Organic compounds
GB0505541D0 (en) Organic compounds
GB0510585D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)